Abstracts

A COMMUNITY-BASED STUDY OF EYE MOVEMENT DESENSITIZATION AND REPROCESSING IN THE PSYCHOLOGICAL TREATMENT OF TRAUMA-BASED PSYCHOGENIC SEIZURES

Abstract number : 3.206
Submission category :
Year : 2005
Submission ID : 6012
Source : www.aesnet.org
Presentation date : 12/3/2005 12:00:00 AM
Published date : Dec 2, 2005, 06:00 AM

Authors :
1Susan D. Kelley, 2Selim R. Benbadis, and 3Dalia Adams

Little is known about types of mental health treatment that is most effective for pseudoseizure patients who have high rates of psychiatric illness, specifically PTSD, depression, and dissociation (Bowman, 2001). Numerous controlled studies and case reports have provided evidence for the efficacy of Eye Movement Desensitization and Reprocessing in the treatment of PTSD, a variety of anxiety disorders, dissociative symptoms, and somatoform disorders. To date, however, there have been no reported studies on using Eye Movement Desensitization and Reprocessing with trauma-based psychogenic seizures. This pilot study integrates Eye Movement Desensitization and Reprocessing into the psychological treeatment of pseudoseizure patients referred after video EEG monitoring confirmed the presence of psychogenic seizures and diagnostic interviews found virtually ubiquitous trauma experiences. Data were analyzed for patients referred from a hospital based clinic serving Floridians and persons from the southeastern U.S. over a 2 year period. The study protocol comprised 2 to 3 initial sessions for diagnosis and rapport building followed by weekly Eye Movement Desensitization and Reprocessing treatment ranging from 3 to 15 sessions. In the majority of patients, psychogenic seizures were either extinguished completely or decreased significantly in severity and frequency. Followup data reveals no return to seizure status for those patients successfully treated with Eye Movement Desensitization and Reprocessing. Eye Movement Desensitization and Reprocessing appears to be a viable intervention in the psychological treatment of psychogenic seizure patients. Further controlled studies will be needed.